Pentasa 500mg Tablet PR
Marketer
Ferring Pharmaceuticals
Salt Composition
Mesalazine (500mg)
Overview Pentasa 500mg Tablet PR
Mesalamine 500mg Delayed-Release Tablets are anti-inflammatory medications indicated for managing ulcerative colitis, a form of inflammatory bowel disease. They alleviate symptoms such as abdominal pain, rectal bleeding, and diarrhea by targeting bowel inflammation. These tablets may also be prescribed for Crohn's ileocolitis. Administer with food, following your physician's precise dosage instructions, tailored to your specific condition. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and disease exacerbation. Commonly reported adverse effects encompass nausea, abdominal discomfort, diarrhea, headache, pruritus, flatulence, and emesis. Report persistent, worsening, or bothersome side effects to your doctor; management strategies may be available. Seek immediate medical assistance for severe allergic reactions, manifested by facial, tongue, throat, or lip swelling; unusual bleeding or bruising; skin rashes; fever; sore throat; or extreme fatigue. Prior to commencing treatment, inform your doctor of any liver or kidney impairment, gastrointestinal obstructions, or relevant medical history, including pregnancy or breastfeeding. Age may influence treatment suitability. Disclose all concurrent medications, as interactions are possible.
Uses of Pentasa 500mg Tablet PR
Inflammatory bowel diseases, encompassing ulcerative colitis and Crohn's disease
Major Benefits of Pentasa 500mg Tablet PR:
Follow your doctor's instructions or consult the product label for proper administration. Pentasa 500mg PR tablets can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Pentasa 500mg Tablet PR:
- Stomach pain/epigastric pain
- Flatulence
- Headache
- Vomiting
- Diarrhea
- Nausea
- Abdominal pain
- Rash
How to use Pentasa 500mg Tablet PR:
Follow your physician's instructions or consult the product label for proper administration. Pentasa 500mg rectal tablets can be ingested with or without food, though consistent timing is recommended.
How Pentasa 500mg Tablet PR works:
Mesalamine 500mg rectal tablets are an aminosalicylate anti-inflammatory. Their mechanism involves inhibiting the synthesis of prostaglandins, mediators of intestinal inflammation. This action lessens ulceration, bleeding, and abdominal discomfort, and helps prevent disease recurrence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Pentasa 500mg tablets rectally. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Pentasa 500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Mesalamine 500mg tablets (rectal) are likely not safe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a risk to the infant. Closely observe infants for diarrhea while mothers use this medication.
DrivingSAFE
Driving ability is typically unaffected by Pentasa 500mg Tablet PR.
KidneyCAUTION
Patients with kidney impairment should use Pentasa 500mg Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Pentasa 500mg Tablet PR; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Pentasa 500mg rectal tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Pentasa 500mg Tablet PR :
Should you forget a Pentasa 500mg Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Pentasa 500mg Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Salicylic Acid Derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Mesalamine (5-ASA) |
3,018 People bought this recently